Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial
Bryan J. M. van de Wall(University of Lucerne), Esther C. J. Consten(University Medical Center Groningen), Ivo A. M. J. Broeders(Meander Medisch Centrum), Willem A. Bemelman(Vrije Universiteit Amsterdam), Rebecca K. Stellato(University Medical Center Utrecht), Boudewijn R. Toorenvliet(Ikazia Ziekenhuis), Werner A. Draaisma(University Medical Center Utrecht), Hubert A. Prins(Jeroen Bosch Ziekenhuis), Marja A. Boermeester(Amsterdam University Medical Centers), Marguerite A W Stam(Meander Medisch Centrum), Eric J. Belgers(Atrium Medisch Centrum Parkstad)
Cited by 168
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Endoscopic Transgastric vs Surgical Necrosectomy for Infected Necrotizing Pancreatitis
|JAMA|2012|735
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698